From virtual to real screening for D3 dopamine receptor ligands

ChemBioChem

Volumn 6, Issue 6, 2005, Pages 997-999

  Byvatov, Evgeny ^a   Sasse, Britta C ^a   Stark, Holger ^a   Schneider, Gisbert ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

Bioinformatics; Drug discovery; G protein coupled receptors; Pharmacophores; Screening; Similarity

Indexed keywords

BP 897; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; DOPAMINE RECEPTOR AFFECTING AGENT; G PROTEIN COUPLED RECEPTOR; LIGAND;

ARTICLE; BINDING AFFINITY; BINDING KINETICS; BIOINFORMATICS; CHEMICAL STRUCTURE; DRUG SCREENING; MACHINE; PHARMACOPHORE; PREDICTION; PRIORITY JOURNAL; RECEPTOR BINDING; SUPPORTIVE VECTOR MACHINE; VIRTUAL REALITY; VIRTUAL SCREENING;

COMPUTATIONAL BIOLOGY; HYDROGEN BONDING; HYDROPHOBICITY; LIGANDS; NITROGEN; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3; RECEPTORS, G-PROTEIN-COUPLED;

EID: 20444502203     PISSN: 14394227     EISSN: None     Source Type: Journal    
DOI: 10.1002/cbic.200400400     Document Type: Article

References (16)

1. a) A. E. Hackling, H. Stark, ChemBioChem 2002, 3, 946-961;
2. b) J. N. Joyce, Pharmacol. Ther. 2001, 90, 231-259.
3. a) J. R. Bunzow, H. H. Van Tol, D. K. Grandy, P. Albert, J. Salon, M. Cristie, C. A. Machida, K. A. Neve, O. Civelli, Nature 1988, 336, 783-787;
4. b) P. Sokoloff, B. Giros, M. P. Martres, M. L. Bouthenet, J. C. Schwartz, Nature 1990, 347, 146-151;
5. c) H. H. Van Tol, J. R. Bunzow, H. C. Guan, R. K. Sunahara, P. Seeman, H. B. Niznik, O. Civelli, Nature 1991, 350, 610-614.
6. a) U. R. Mach, A. E. Hackling, S. Perachon, S. Ferry, C. G. Wermuth, J. C. Schwarz, P. Sokoloff, H. Stark, ChemBioChem 2004, 5, 508-518;
7. b) A. E. Hackling, R. Ghosh, S. Perachon, A. Mann, H. D. Höltje, C. G. Wermuth, J. C. Schwarz, W. Sippl, P. Sokoloff, H. Stark, J. Med. Chem. 2003, 46, 3883-3899.
8. MOE (Molecular Operating Environment) version 2004.05 by Chemical Computing Group, Inc., Montréal (Canada) http://www.chemcomp.com
9. M. Pilla, S. Perachon, F. Sautel, F. Garridol, A. Mann, C. G. Wermuth, J. C. Schwartz, B. J. Everitt, P. Sokoloff, Nature 1999, 400, 371-375.
10. a) G. Schneider, P. Schneider in Chemogenomics in Drug Discovery (Eds.: H. Kubinyi, G. Müller), Wiley-VCH, Weinheim, 2004, pp. 341 -376;
11. b) E. Byvatov, G. Schneider, Appl. Bioinf. 2003, 2, 67-77.
12. T. Joachims in Advances in Kernel Methods-Support Vector Learning (Eds.: B. Schölkopf, C. Burges, A. Smola), MIT-Press, Cambridge, MA, 1999, pp. 41-56.
13. a) E. Byvatov, G. Schneider, J. Chem. Inf. Comput. Sci. 2004, 44, 993-999;
14. b) E. Byvatov, U. Fechner, J. Sadowski, G. Schneider, J. Chem. Inf. Comput. Sci. 2003, 43, 1882-1889.
15. a) M. J. Mokrosz, P. Kowalski, T. Kowalska, Arch. Pharm. 1999, 332, 373-379;
16. b) M. J. Mokroz, S. Charakchieva-Minol, P. Kowalski, Arch. Pharm. 2001, 334, 25-29.